Mechanisms of pruritogen‐induced activation of itch nerves in isolated mouse skin

Key points Chloroquine (CQ) stimulates itch nerves and causes intense scratching in mice by activating the G‐protein coupled receptor (GPCR) MrgprA3; it is not known how stimulation of MrgprA3 (or other GPCRs) leads to activation of the itch nerve terminals in the skin, but previous studies have fou...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of physiology Vol. 595; no. 11; pp. 3651 - 3666
Main Authors: Ru, F., Sun, H., Jurcakova, D., Herbstsomer, R. A., Meixong, J., Dong, X., Undem, B. J.
Format: Journal Article
Language:English
Published: England Wiley Subscription Services, Inc 01-06-2017
John Wiley and Sons Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Key points Chloroquine (CQ) stimulates itch nerves and causes intense scratching in mice by activating the G‐protein coupled receptor (GPCR) MrgprA3; it is not known how stimulation of MrgprA3 (or other GPCRs) leads to activation of the itch nerve terminals in the skin, but previous studies have found that transient receptor potential A1 (TRPA1) gene deletion blocks CQ‐induced scratching. In the present study we used a novel dorsal skin–nerve preparation to evaluate mechanisms underlying CQ‐ and histamine‐induced action potential discharge in itch nerve terminals. We found that CQ activation of the nerves requires the beta3 isoform of phospholipase C, but TRPA1 or other TRP channel are not required. Evidence is provided for a role for calcium‐activated chloride channels such as TMEM16a in GPCR‐activation of itch nerve terminals. The mechanism by which TRP channels participate in pruritogen‐induced scratching may involve sites of action other than the primary afferent terminals. Chloroquine (CQ) and histamine are pruritogens commonly used to study itch in the mouse. A novel skin–nerve preparation was used to evaluate chloroquine (CQ)‐ and histamine‐induced activation of afferent nerves in the dorsal thoracic skin of the mouse. All CQ sensitive nerves were C‐fibres, and were also sensitive to histamine. The response to CQ, but not histamine, was largely absent in mrgpr‐cluster Δ−/− mice, supporting the hypothesis that CQ evokes itch largely via stimulation of MrgprA3 receptors. The CQ‐induced action potential discharge was largely absent in phospholipase Cβ3 knockout animals. The CQ and histamine responses were not influenced by removal of TRPA1, TRPV1, TRPC3 or TRPC6, nor by the TRP channel blocker Ruthenium Red. The bouts of scratching in response to CQ were not different between wild‐type and TRPA1‐deficient mice. A selective inhibitor of the calcium‐activated chloride channel TMEM16A, N‐((4‐methoxy)‐2‐naphthyl)‐5‐nitroanthranilic acid (MONNA), inhibited CQ‐induced action potential discharge at itch nerve terminals and bouts of scratching by about 50%. Although TRPA1 and TRPV1 channels may be involved in the scratching responses to intradermal pruritogens, this is unlikely to be due to an effect at the nerve terminals, where chloride channels may play a more important role. Key points Chloroquine (CQ) stimulates itch nerves and causes intense scratching in mice by activating the G‐protein coupled receptor (GPCR) MrgprA3; it is not known how stimulation of MrgprA3 (or other GPCRs) leads to activation of the itch nerve terminals in the skin, but previous studies have found that transient receptor potential A1 (TRPA1) gene deletion blocks CQ‐induced scratching. In the present study we used a novel dorsal skin–nerve preparation to evaluate mechanisms underlying CQ‐ and histamine‐induced action potential discharge in itch nerve terminals. We found that CQ activation of the nerves requires the beta3 isoform of phospholipase C, but TRPA1 or other TRP channel are not required. Evidence is provided for a role for calcium‐activated chloride channels such as TMEM16a in GPCR‐activation of itch nerve terminals. The mechanism by which TRP channels participate in pruritogen‐induced scratching may involve sites of action other than the primary afferent terminals.
Bibliography:https://doi.org/10.1113/JP274199
This article is highlighted by a Perspective by Gamper. To read this Perspective, visit
Linked articles
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Linked articles This article is highlighted by a Perspective by Gamper. To read this Perspective, visit https://doi.org/10.1113/JP274199.
ISSN:0022-3751
1469-7793
DOI:10.1113/JP273795